hVIVO takes a major step towards £100m revenue target with German deal
Portfolio Pulse from
hVIVO PLC has acquired two clinical research units in Germany for £8.4 million, aiming to reach £100 million in revenue by 2028. This acquisition adds 120 beds to its facilities, enhancing its capacity for early-stage clinical trials.
January 29, 2025 | 8:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
hVIVO PLC has acquired two clinical research units in Germany for £8.4 million, adding 120 beds to its facilities. This move is part of its strategy to reach £100 million in revenue by 2028.
The acquisition of the German clinical research units significantly enhances hVIVO's capacity for early-stage clinical trials, which is crucial for its growth strategy. This move is likely to positively impact its revenue and market position, aligning with its goal of reaching £100 million in revenue by 2028.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100